Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target "Calcium ions on sialylated N-linked glycans" refers to a specific molecular motif where divalent calcium ions coordinate with negatively charged sialic acid residues on N-linked carbohydrate chains of glycoproteins. This interaction is a critical structural and functional feature of several biological systems, most notably in the binding of C-type lectins like selectins to their ligands during leukocyte trafficking and inflammation. In the vascular system, P-selectin utilizes a calcium ion in its binding pocket to recognize sialylated and fucosylated glycans, such as Sialyl-Lewis X, on the surface of leukocytes, a process essential for cell rolling and recruitment to sites of injury. Beyond adhesion, these sialic acid-calcium complexes on voltage-gated ion channels modulate channel gating by influencing the local electrostatic environment and cation concentration near the pore. Therapeutically, this interaction is targeted by selectin inhibitors like crizanlizumab to treat vaso-occlusive crises in sickle cell disease, and by sialidases like DAS181 which remove the sialic acid residues to prevent viral entry or modulate neuronal excitability. The target represents a complex biochemical site involving both the glycan structure and the coordinating cation rather than a single protein molecule.
P-selectin inhibition, Sialic acid cleavage (sialidase activity), Competitive inhibition of glycan binding, Neuraminidase inhibition
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium ions on sialylated N-linked glycans.